Live Breaking News & Updates on Oderna

Stay informed with the latest breaking news from Oderna on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Oderna and stay connected to the pulse of your community

Moderna CEO wants employees to use ChatGPT 20 times a day

Stéphane Bancel said the pharma company's partnership with OpenAI will help transform its business

Sam-altman , Wall-street , Chatgpt , Oderna , Usiness , Inance , Penai , Enerative-pre-trained-transformer , Am-altman , Oderna-covid-19-vaccine , Lon-musk

Pfizer vs Moderna battle over COVID vaccine patents begins in UK

Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.

London , City-of , United-kingdom , United-states , Germany , Belgium , Netherlands , German , Sachin-ravikumar , Sam-tobin , Biontech-comirnaty , High-court

Moderna (MRNA) Stock Moves -0.58%: What You Should Know

Moderna (MRNA) reachead $101.41 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close.

Nasdaq , Zacks-investment-research , Zacks-consensus-estimates , Zacks-rank , Strong-buy , Strong-sell , Zacks-consensus , Zacks-industry-rank , Zacks-investment , Oderna , Edical-sector

Moderna's cancer vax, AstraZeneca CEO's big pay, record-high drug shortages

Plus, Harrow hikes the price of its eye medication 486%, and Pfizer wants the first FDA approval ever for an RSV vaccine for young adults

United-states , American , Pfizer , American-society-of-health , American-society , Health-system-pharmacists , Astrazeneca , Oderna , Ovartis , Denoviridae , Ealth

Shanghai planning US$13.8 billion fund of funds in pursuit of 'several world-class industry clusters', with eye on AI, biotech and semiconductors

Mainland China’s commercial and financial hub plans to set up a 100 billion yuan (US$13.8 billion) fund of funds focusing on key technology sectors to fire up the local economy.

Beijing , China , Zhejiang , Shanghai , Wang-feng , Anhui , Boston , Massachusetts , United-states , Ye-lang , Guizhou , Chinese